Compared with non-encapsulated curcumin, curcumin-primed sEVs enhanced the stability, and bioavailability of curcumin, inhibiting tau phosphorylation mediated by the AKT/GSK-3β pathway, thus contributing to the effective amelioration of learning and memory deficiencies in the induced-AD mice. Here, MAPT is linked to Alzheimer disease.